• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性关节病患者滑液和血清中的软骨蛋白聚糖。与全身治疗的关系。

Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.

作者信息

Saxne T, Heinegård D, Wollheim F A

机构信息

Department of Rheumatology, University Hospital, Lund, Sweden.

出版信息

Arthritis Rheum. 1987 Sep;30(9):972-9. doi: 10.1002/art.1780300903.

DOI:10.1002/art.1780300903
PMID:3663262
Abstract

Proteoglycan concentrations in knee joint synovial fluid and in serum from patients with various inflammatory arthritides were studied using an enzyme-linked immunosorbent assay. Patients with reactive arthritis, calcium pyrophosphate arthropathy, and juvenile rheumatoid arthritis (age less than or equal to 20 years) had the highest synovial fluid concentrations. These values differed significantly (P less than 0.001) from those in patients with rheumatoid arthritis, psoriatic arthropathy, and chronic HLA-B27-associated arthropathy. Rheumatoid arthritis patients receiving low-dose prednisolone treatment had higher synovial fluid (P = 0.006) and serum (P less than 0.001) proteoglycan concentrations than did those taking nonsteroidal antiinflammatory drugs or slow-acting antirheumatic drugs. Serum proteoglycan concentrations were near the detection limits, and did not correlate with levels found in paired samples of knee joint synovial fluid. Patients with calcium pyrophosphate arthropathy had the highest mean serum level of proteoglycan. This assay of proteoglycan antigens is a useful tool in the study of proteoglycan metabolism in patients with joint disease. With its use, differences between disease groups and effects of therapy can be distinguished.

摘要

采用酶联免疫吸附测定法研究了各种炎性关节炎患者膝关节滑液和血清中的蛋白聚糖浓度。反应性关节炎、焦磷酸钙关节病和幼年类风湿关节炎(年龄小于或等于20岁)患者的滑液浓度最高。这些值与类风湿关节炎、银屑病关节炎和慢性HLA - B27相关关节病患者的值有显著差异(P小于0.001)。接受低剂量泼尼松龙治疗的类风湿关节炎患者的滑液(P = 0.006)和血清(P小于0.001)蛋白聚糖浓度高于服用非甾体抗炎药或慢作用抗风湿药的患者。血清蛋白聚糖浓度接近检测限,与膝关节滑液配对样本中的水平无关。焦磷酸钙关节病患者的蛋白聚糖平均血清水平最高。这种蛋白聚糖抗原检测方法是研究关节疾病患者蛋白聚糖代谢的有用工具。通过使用该方法,可以区分疾病组之间的差异和治疗效果。

相似文献

1
Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.炎症性关节病患者滑液和血清中的软骨蛋白聚糖。与全身治疗的关系。
Arthritis Rheum. 1987 Sep;30(9):972-9. doi: 10.1002/art.1780300903.
2
Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.通过蛋白聚糖结构释放到滑液中所衡量的对关节炎软骨代谢的治疗效果。
Ann Rheum Dis. 1986 Jun;45(6):491-7. doi: 10.1136/ard.45.6.491.
3
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.早期类风湿关节炎和反应性关节炎滑液中软骨蛋白聚糖水平的差异。
Lancet. 1985 Jul 20;2(8447):127-8. doi: 10.1016/s0140-6736(85)90229-6.
4
A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease.一种用于定量在退行性关节病发展过程中释放到滑液中的软骨蛋白聚糖结构的方法。
Scand J Clin Lab Invest. 1985 Sep;45(5):421-7. doi: 10.1080/00365518509155238.
5
Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.急性而非慢性关节疾病患者滑液中蛋白聚糖成分浓度升高。
Ann Rheum Dis. 1988 Oct;47(10):826-32. doi: 10.1136/ard.47.10.826.
6
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.白细胞介素-1β和蛋白聚糖的滑液浓度呈负相关。
J Autoimmun. 1988 Aug;1(4):373-80. doi: 10.1016/0896-8411(88)90007-8.
7
Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy.骨关节炎和焦磷酸关节病患者滑液中硫酸角质素浓度及蛋白聚糖大小分布的比较。
Rheumatol Int. 1991;11(2):63-8. doi: 10.1007/BF00291147.
8
Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.人关节炎滑液影响牛鼻软骨器官培养中蛋白聚糖的生物合成和降解。
Coll Relat Res. 1988 May;8(3):233-47. doi: 10.1016/s0174-173x(88)80043-8.
9
Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood.软骨寡聚基质蛋白:一种可在滑液和血液中检测到的软骨更新的新型标志物。
Br J Rheumatol. 1992 Sep;31(9):583-91. doi: 10.1093/rheumatology/31.9.583.
10
The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.类风湿性关节炎或反应性关节炎患者血清和滑液中的氨基末端III型前胶原肽和蛋白聚糖。
Rheumatol Int. 1988;8(1):1-9. doi: 10.1007/BF00541343.

引用本文的文献

1
The role of crystals in articular tissue degeneration.晶体在关节组织退变中的作用。
Curr Rheumatol Rep. 1999 Dec;1(2):128-31. doi: 10.1007/s11926-999-0009-1.
2
Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease.评估马滑液中糖胺聚糖浓度作为关节疾病标志物的情况。
Can J Vet Res. 1995 Jul;59(3):205-12.
3
Intrasynovial levels of sulphated glycosaminoglycans and autoantibodies to type II collagen in rheumatoid arthritis: a correlative analysis.类风湿关节炎中滑膜内硫酸化糖胺聚糖水平及抗II型胶原自身抗体:相关性分析
Rheumatol Int. 1993;13(1):15-20. doi: 10.1007/BF00290329.
4
Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.关节炎中软骨代谢的变化通过软骨蛋白聚糖聚集蛋白聚糖血清和滑液水平的改变得以体现。对发病机制的影响。
J Clin Invest. 1994 Jul;94(1):25-33. doi: 10.1172/JCI117314.
5
Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence.非甾体抗炎药与软骨保护。证据综述。
Drugs. 1993 Nov;46(5):834-46. doi: 10.2165/00003495-199346050-00004.
6
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?滑液中蛋白聚糖浓度:类风湿关节炎未来软骨破坏的预测指标?
Br Med J (Clin Res Ed). 1987 Dec 5;295(6611):1447-8. doi: 10.1136/bmj.295.6611.1447.
7
Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid.关节炎性滑液中硫酸化糖胺聚糖和蛋白聚糖片段的测量
Ann Rheum Dis. 1989 Jan;48(1):17-24. doi: 10.1136/ard.48.1.17.
8
Application of an enzyme-linked immunosorbent-inhibition assay to quantitate the release of KS peptides into fluids of the rat subcutaneous air-pouch model and the effects of chondroprotective drugs on the release process.应用酶联免疫吸附抑制试验定量测定大鼠皮下气囊模型中KS肽向液体中的释放以及软骨保护药物对释放过程的影响。
Rheumatol Int. 1989;9(2):77-83. doi: 10.1007/BF00270249.
9
Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.急性而非慢性关节疾病患者滑液中蛋白聚糖成分浓度升高。
Ann Rheum Dis. 1988 Oct;47(10):826-32. doi: 10.1136/ard.47.10.826.
10
Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.类风湿关节炎患者滑液中的胞苷脱氨酶活性:与乳铁蛋白、酸中毒及软骨蛋白聚糖释放的关系
Ann Rheum Dis. 1990 Aug;49(8):594-7. doi: 10.1136/ard.49.8.594.